Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants
The results are reported from the treatment of seven patients with severe diffuse chronic glomerulonephritis in Schönlein--Henoch disease with manifested clinical and laboratory manifestations (nephrotic syndromes, arterial hypertension, anemia, renal insufficiency, chronic from of the syndrome of disseminated intravascular coagulation). Combined treatment with anticoagulants (heparin and acenocoumarol), corticosteroids (with initial introducing "pulse" trarment with 300 mg methylprednisolone) and immunosuppressors was administered to all. Complete clinical-laboratory remission was attained in 57.1% of the patients, and in 28.5%--partical. One of the patients died from mesenterial thrombosis. The anticoagulants and "pulse" treatment with high corticosteroid doses are of the greatest importance for the favourable therapeutic result.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1986 |
|---|---|
| Erschienen: |
1986 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Vutreshni bolesti - 25(1986), 2 vom: 15., Seite 21-5 |
| Sprache: |
Bulgarisch |
|---|
| Weiterer Titel: |
Lechenie na difuznite glomerulonefriti u vŭzrastni s bolestta na Schönlein-Henoch s kombinatsiia ot antikoagulanti, kortikosteroidi i imunosupresori |
|---|
| Beteiligte Personen: |
Belovezhdov, N [VerfasserIn] |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 16.07.1986 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM03697627X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM03697627X | ||
| 003 | DE-627 | ||
| 005 | 20231221140039.0 | ||
| 007 | tu | ||
| 008 | 231221s1986 xx ||||| 00| ||bul c | ||
| 028 | 5 | 2 | |a pubmed24n0124.xml |
| 035 | |a (DE-627)NLM03697627X | ||
| 035 | |a (NLM)3716373 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a bul | ||
| 100 | 1 | |a Belovezhdov, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants |
| 246 | 3 | 3 | |a Lechenie na difuznite glomerulonefriti u vŭzrastni s bolestta na Schönlein-Henoch s kombinatsiia ot antikoagulanti, kortikosteroidi i imunosupresori |
| 264 | 1 | |c 1986 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 16.07.1986 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The results are reported from the treatment of seven patients with severe diffuse chronic glomerulonephritis in Schönlein--Henoch disease with manifested clinical and laboratory manifestations (nephrotic syndromes, arterial hypertension, anemia, renal insufficiency, chronic from of the syndrome of disseminated intravascular coagulation). Combined treatment with anticoagulants (heparin and acenocoumarol), corticosteroids (with initial introducing "pulse" trarment with 300 mg methylprednisolone) and immunosuppressors was administered to all. Complete clinical-laboratory remission was attained in 57.1% of the patients, and in 28.5%--partical. One of the patients died from mesenterial thrombosis. The anticoagulants and "pulse" treatment with high corticosteroid doses are of the greatest importance for the favourable therapeutic result | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Vutreshni bolesti |d 1971 |g 25(1986), 2 vom: 15., Seite 21-5 |w (DE-627)NLM000055662 |x 0506-2772 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:1986 |g number:2 |g day:15 |g pages:21-5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 1986 |e 2 |b 15 |h 21-5 | ||